MS-2222

MS-2222

A 65-year-old woman is scheduled to receive a heart transplant for severe congestive heart failure with an ejection fraction of 30%. She has been prescribed tacrolimus to minimize the risk of organ rejection.

What should be monitored due to her new medication?